These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6148792)

  • 21. [Pharmacopsychiatry and iatrogenic parkinsonism].
    Pérez de Francisco C; Garnica Portillo R
    Neurol Neurocir Psiquiatr; 1978; 19(1):53-7. PubMed ID: 30054
    [No Abstract]   [Full Text] [Related]  

  • 22. [Main side effects of the use of neuroleptics].
    Morato GS; Takahashi RN
    AMB Rev Assoc Med Bras; 1982; 28(11-12):247-9. PubMed ID: 6133319
    [No Abstract]   [Full Text] [Related]  

  • 23. Followup studies of tardive dyskinesia cases.
    Huang CC
    Wis Med J; 1984 Dec; 83(12):27-9. PubMed ID: 6151758
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central atropine-like toxicity in combined psychotropic drug administration.
    el-Yousef MK; Davis JM; Janowsky DS; Fann WE
    J Tenn Med Assoc; 1972 Aug; 65(8):719. PubMed ID: 4152620
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavioral interactions induced by chronic neuroleptic therapy in persons with mental retardation.
    Schroeder SR; Gualtieri CT
    Psychopharmacol Bull; 1985; 21(2):310-5. PubMed ID: 2860695
    [No Abstract]   [Full Text] [Related]  

  • 27. Tardive dyskinesia and antiparkinsonian medication.
    Chouinard G; De Montigny C; Annable L
    Am J Psychiatry; 1979 Feb; 136(2):228-9. PubMed ID: 32778
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and neurobiologic implications of antipsychotic-induced movement disorders.
    Rubin EH; Zorumski CF
    Compr Ther; 1986 Oct; 12(10):61-7. PubMed ID: 2877769
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs.
    Toru M; Matsuda O; Makiguchi K; Sugano K
    J Nerv Ment Dis; 1981 May; 169(5):324-7. PubMed ID: 6111584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse.
    Moncrieff J
    Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC; Chew EL; Ong YY
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic trial of tiapride in extrapyramidal syndromes caused by neuroleptics].
    Zarranz JJ; Caso C; Blanco J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1980; 8(6):503-8. PubMed ID: 6110319
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroleptic-induced movement disorders: deconstructing extrapyramidal symptoms.
    Trosch RM
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S266-71. PubMed ID: 15541167
    [No Abstract]   [Full Text] [Related]  

  • 34. Extrapyramidal side effects of antipsychotic medications.
    Harris E
    Am J Nurs; 1981 Jul; 81(7):1324-8. PubMed ID: 6113762
    [No Abstract]   [Full Text] [Related]  

  • 35. Tardive dyskinesia: a concern for the pediatrician.
    Singer HS
    Pediatrics; 1986 Apr; 77(4):553-6. PubMed ID: 2870466
    [No Abstract]   [Full Text] [Related]  

  • 36. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuroleptics and antidepressants].
    Kojima T; Tada K
    No To Shinkei; 1992 Dec; 44(12):1077-82. PubMed ID: 1363591
    [No Abstract]   [Full Text] [Related]  

  • 38. [Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease].
    Höflich G; Burghof KW; Kasper S; Möller HJ
    Nervenarzt; 1994 Mar; 65(3):202-5. PubMed ID: 7909917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology in the elderly: psychological and physiological interrelationships.
    Hooyman NW; Gambert SR
    Psychiatr Med; 1983 Dec; 1(4):445-58. PubMed ID: 6152848
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
    Bezchlibnyk-Butler KZ; Remington GJ
    Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.